Curcumin induces M2 macrophage polarization by secretion IL-4 and/or IL-13

Journal of Molecular and Cellular Cardiology

Volumn 85, Issue , 2015, Pages 131-139

  Gao, Shanshan ^a   Zhou, Juan ^a,b   Liu, Na ^c   Wang, Lijun ^a,b   Gao, Qiyue ^a   Wu, Yan ^a   Zhao, Qiang ^a   Liu, Peining ^a   Wang, Shun ^a   Liu, Yan ^a   Guo, Ning ^a   Shen, Yan ^a   Wu, Yue ^a   Yuan, Zuyi ^a,b  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c The Second Hospital of YuLin   (China)

Author keywords

Curcumin; Experimental autoimmune myocarditis; M2 macrophages

Indexed keywords

ARGINASE 1; CD68 ANTIGEN; CURCUMIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; LEFLUNOMIDE; MANNOSE RECEPTOR; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STAT6 PROTEIN; CARDIOTONIC AGENT; STAT6 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARDIOVASCULAR PARAMETERS; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RELEASE; EXPERIMENTAL AUTOIMMUNE DISEASE; EXPERIMENTAL AUTOIMMUNE MYOCARDITIS; HEART EJECTION FRACTION; HEART PROTECTION; HEART RATE; IN VIVO STUDY; INFLAMMATORY CELL; LEFT VENTRICULAR ENDSYSTOLIC DIAMETER; LEFT VENTRICULAR FRACTIONAL SHORTENING; MACROPHAGE; MALE; MYOCARDITIS; NONHUMAN; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; UPREGULATION; ANIMAL; CARDIAC MUSCLE; CELL LINE; CELL POLARITY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; IMMUNOLOGY; LEWIS RAT; METABOLISM; MOUSE; PATHOLOGY; PRECLINICAL STUDY; SECRETION (PROCESS);

RATTUS; ZEA MAYS;

ANIMALS; CARDIOTONIC AGENTS; CELL LINE; CELL POLARITY; CURCUMIN; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION; INTERLEUKIN-13; INTERLEUKIN-4; MACROPHAGES; MALE; MICE; MYOCARDITIS; MYOCARDIUM; RATS, INBRED LEW; STAT6 TRANSCRIPTION FACTOR; UP-REGULATION;

EID: 84930634376     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.04.025     Document Type: Article

References (39)

1. Gordon S., Martinez F.O. Alternative activation of macrophages: mechanism and functions. Immunity 2010, 32(5):593-604.
2. Galkina E., Ley K. Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol 2009, 27:165-197.
3. Nagareddy P.R., Kraakman M., Masters S.L., Stirzaker R.A., Gorman D.J., Grant R.W., et al. Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity. Cell Metab 2014, 19(5):821-835.
4. Eguchi K., Manabe I. Macrophages and islet inflammation in type 2 diabetes. Diabetes Obes Metab 2013, 15(Suppl. 3):152-158.
5. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008, 8(12):958-969.
6. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25(12):677-686.
7. Stout R.D., Jiang C., Matta B., Tietzel I., Watkins S.K., Suttles J. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 2005, 175(1):342-349.
8. Banerjee M., Tripathi L.M., Srivastava V.M., Puri A., Shukla R. Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat. Immunopharmacol Immunotoxicol 2003, 25(2):213-224.
9. Aggarwal B.B., Kumar A., Bharti A.C. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003, 23(1A):363-398.
10. Durgaprasad S., Pai C.G., Vasanthkumar, Alvres J.F., Namitha S. A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. Indian J Med Res 2005, 122(4):315-318.
11. Wongcharoen W., Phrommintikul A. The protective role of curcumin in cardiovascular diseases. Int J Cardiol 2009, 133(2):145-151.
12. Chen F., Guo N., Cao G., Zhou J., Yuan Z. Molecular analysis of curcumin-induced polarization of murine RAW264.7 macrophages. J Cardiovasc Pharmacol 2014, 63(6):544-552.
13. Watanabe K., Ohta Y., Nakazawa M., Higuchi H., Hasegawa G., Naito M., et al. Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy. Br J Pharmacol 2000, 130(7):1489-1495.
14. Mito S., Watanabe K., Harima M., Thandavarayan R.A., Veeraveedu P.T., Sukumaran V., et al. Curcumin ameliorates cardiac inflammation in rats with autoimmune myocarditis. Biol Pharm Bull 2011, 34(7):974-979.
15. Wang L., Gao S., Xu W., Zhao S., Zhou J., Wang N., et al. Allergic asthma accelerates atherosclerosis dependent on Th2 and Th17 in apolipoprotein E deficient mice. J Mol Cell Cardiol 2014, 72:20-27.
16. Yuan Z., Liu Y., Liu Y., Zhang J., Kishimoto C., Ma A., et al. Peroxisome proliferator-activated receptor-gamma ligands ameliorate experimental autoimmune myocarditis associated with inhibition of self-sensitive T cells. J Cardiovasc Pharmacol 2004, 43(6):868-875.
17. Sica A., Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 2007, 117(5):1155-1166.
18. Smerz-Bertling C., Duschl A. Both interleukin 4 and interleukin 13 induce tyrosine phosphorylation of the 140-kDa subunit of the interleukin 4 receptor. J Biol Chem 1995, 270(2):966-970.
19. Yu C.R., Kirken R.A., Malabarba M.G., Young H.A., Ortaldo J.R. Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary human NK and T cells: a comparative study with IL-4. J Immunol 1998, 161(1):218-227.
20. Sica A., Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 2012, 122(3):787-795.
21. Pae H.O., Jeong S.O., Kim H.S., Kim S.H., Song Y.S., Kim S.K., et al. Dimethoxycurcumin, a synthetic curcumin analogue with higher metabolic stability, inhibits NO production, inducible NO synthase expression and NF-kappaB activation in RAW264.7 macrophages activated with LPS. Mol Nutr Food Res 2008, 52(9):1082-1091.
22. Chen D., Nie M., Fan M.W., Bian Z. Anti-inflammatory activity of curcumin in macrophages stimulated by lipopolysaccharides from Porphyromonas gingivalis. Pharmacology 2008, 82(4):264-269.
23. Teiten M.H., Dicato M., Diederich M. Curcumin as a regulator of epigenetic events. Mol Nutr Food Res 2013, 57(9):1619-1629.
24. Shu L., Khor T.O., Lee J.H., Boyanapalli S.S., Huang Y., Wu T.Y., et al. Epigenetic CpG demethylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells. AAPS J 2011, 13(4):606-614.
25. Yang X., Wang X., Liu D., Yu L., Xue B., Shi H. Epigenetic regulation of macrophage polarization by DNA methyltransferase 3b. Mol Endocrinol 2014, 28(4):565-574.
26. Zhu J., Yamane H., Cote-Sierra J., Guo L., Paul W.E. GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res 2006, 16(1):3-10.
27. Knosp C.A., Johnston J.A. Regulation of CD4+ T-cell polarization by suppressor of cytokine signalling proteins. Immunology 2012, 135(2):101-111.
28. Junttila I.S., Mizukami K., Dickensheets H., Meier-Schellersheim M., Yamane H., Donnelly R.P., et al. Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Ralpha, IL-13Ralpha1, and gammac regulates relative cytokine sensitivity. J Exp Med 2008, 205(11):2595-2608.
29. Liao X., Sharma N., Kapadia F., Zhou G., Lu Y., Hong H., et al. Kruppel-like factor 4 regulates macrophage polarization. J Clin Invest 2011, 121(7):2736-2749.
30. Bouhlel M.A., Derudas B., Rigamonti E., Dievart R., Brozek J., Haulon S., et al. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab 2007, 6(2):137-143.
31. Smith S.C., Allen P.M. Myosin-induced acute myocarditis is a T cell-mediated disease. J Immunol 1991, 147(7):2141-2147.
32. Palaniyandi S.S., Watanabe K., Ma M., Tachikawa H., Kodama M., Aizawa Y. Inhibition of mast cells by interleukin-10 gene transfer contributes to protection against acute myocarditis in rats. Eur J Immunol 2004, 34(12):3508-3515.
33. Matsui Y., Okamoto H., Jia N., Akino M., Uede T., Kitabatake A., et al. Blockade of macrophage migration inhibitory factor ameliorates experimental autoimmune myocarditis. J Mol Cell Cardiol 2004, 37(2):557-566.
34. Khallou-Laschet J., Varthaman A., Fornasa G., Compain C., Gaston A.T., Clement M., et al. Macrophage plasticity in experimental atherosclerosis. PLoS One 2010, 5(1):e8852.
35. Nishikawa K., Seo N., Torii M., Ma N., Muraoka D., Tawara I., et al. Interleukin-17 induces an atypical M2-like macrophage subpopulation that regulates intestinal inflammation. PLoS One 2014, 9(9):e108494.
36. Marchetti V., Yanes O., Aguilar E., Wang M., Friedlander D., Moreno S., et al. Differential macrophage polarization promotes tissue remodeling and repair in a model of ischemic retinopathy. Sci Rep 2011, 1:76.
37. Fairweather D., Cihakova D. Alternatively activated macrophages in infection and autoimmunity. J Autoimmun 2009, 33(3-4):222-230.
38. Jiang Z., Jiang J.X., Zhang G.X. Macrophages: a double-edged sword in experimental autoimmune encephalomyelitis. Immunol Lett 2014, 160(1):17-22.
39. Cihakova D., Barin J.G., Afanasyeva M., Kimura M., Fairweather D., Berg M., et al. Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation. Am J Pathol 2008, 172(5):1195-1208.